Delivery Order SPE2DX22D0010-SPE2D826FAV96
Award Date 11/5/25
Potential Completion Date 11/6/25
Potential Value $21K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse (lisdexamfetamine) 30mg capsules under a firm fixed-price contract with a ceiling value of $30,816.60. This delivery order, awarded on September 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical. The award was competitively awarded with no set-aside designation...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,658.76 to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (30 mg) on August 20, 2025. This firm fixed-price delivery order, which is expected to be completed by August 21, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The award was competitively procured with no set-aside designation, leveraging...
- The Department of Defense's Medical Supply Chain awarded a $26,751.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse capsules (50mg) on October 3, 2025, with an ultimate completion date of October 6, 2025. This non-compete, competitively awarded contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at $999,999,999.00 and extending through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on October 6, 2025, for the supply of Vyvanse capsules (20 mg) valued at $3,108.21. This firm fixed-price contract, which is set to be completed by October 7, 2025, supports the Medical Supply Chain division of the Defense Logistics Agency. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The U.S. Defense Department's Medical Supply Chain awarded AmerisourceBergen Drug Corp a $23,091.44 delivery order on October 22, 2025, for Vyvanse capsules (60mg), a stimulant medication commonly used to treat attention-deficit/hyperactivity disorder. This firm fixed-price contract, which is non-set-aside and competitively awarded, is scheduled for completion by October 23, 2025, with performance occurring at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Vyvanse 20mg tablets (100 count) valued at $32,104.80. This firm fixed price delivery order, with an ultimate completion date of September 5, 2025, represents a non-competitive award under the company's existing Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The product will be delivered to...
- The Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Vyvanse (lisdexamfetamine dimesylate) 50mg capsules under a firm fixed-price contract valued at $25,229.11, with a completion date of April 22, 2025. This non-competitive delivery order was issued on April 21, 2025, and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a single-product pharmaceutical procurement typical of the...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for Vyvanse capsules (50mg) valued at $12,583.48 under a firm fixed-price contract. The award was made on November 4, 2025, with an ultimate completion date of November 5, 2025, with no set-aside designation. The order will be fulfilled from the contractor's corporate office location in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its headquarters as a major pharmaceutical...
- The Defense Department's Medical Supply Chain awarded a delivery order valued at $21,817.12 to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Vyvanse capsules 40mg, with completion scheduled for April 23, 2025. This firm fixed-price delivery order represents a non-competitive award to the prime contractor and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order valued at $13,562.15 to AmerisourceBergen Drug Corp for Vyvanse 50mg capsules. This firm fixed-price contract, issued on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical...